Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Gang Wei

Matched on ORCID iD 0000-0001-5839-1276; OpenAlex author ID A5066354708. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 6

  1. The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating P… Co-author DOI 10.1002/ctm2.654↗
  2. Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer. Last author DOI 10.1155/2020/1570862↗
  3. Perineural invasion is related to p38 mitogen-activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancer. Co-author DOI 10.1002/jcb.28457↗
  4. Corrigendum to "GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer" [Cancer Le… Co-author DOI 10.1016/j.canlet.2019.03.031↗
  5. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes. Co-author DOI 10.1016/j.canlet.2017.09.044↗
  6. GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.06.016↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenghong Peng · 5 shared papers, 2016–2022 · strength 0.41
  2. Hao Chen · 5 shared papers, 2016–2022 · strength 0.41
  3. Jiangning Gu · 5 shared papers, 2016–2020 · strength 0.38
  4. Baiyong Shen · 4 shared papers, 2016–2022 · strength 0.34
  5. Youwei Zhu · 3 shared papers, 2018–2022 · strength 0.28
  6. Xiaxing Deng · 3 shared papers, 2016–2022 · strength 0.27
  7. Di Wang · 3 shared papers, 2018–2020 · strength 0.25
  8. Zhiqiang Zhang · 2 shared papers, 2020–2022 · strength 0.23
  9. Qian Zhan · 2 shared papers, 2016–2019 · strength 0.14
  10. Yi Zhu · 2 shared papers, 2016–2019 · strength 0.14
  11. Yizhi Cao · 1 shared paper, 2022 · strength 0.13
  12. Yihao Liu · 1 shared paper, 2022 · strength 0.13
  13. Guang Tan · 1 shared paper, 2020 · strength 0.10
  14. Haifeng Luo · 1 shared paper, 2020 · strength 0.10
  15. Jian Du · 1 shared paper, 2020 · strength 0.10
  16. Shulin Zhao · 1 shared paper, 2019 · strength 0.08
  17. Dongfeng Cheng · 1 shared paper, 2019 · strength 0.08
  18. Jiabin Jin · 1 shared paper, 2019 · strength 0.08
  19. Bosen Zhang · 1 shared paper, 2018 · strength 0.07
  20. Ouyang Ge · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.